Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study

Approximately 30% of patients with schizophrenia do not respond to antipsychotics and are thus considered to have treatment-resistant schizophrenia (TRS). To date, only four studies have examined glutamatergic neurometabolite levels using proton magnetic resonance spectroscopy ((1)H-MRS) in patients...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuropsychopharmacology
Auteurs principaux: Tarumi, Ryosuke, Tsugawa, Sakiko, Noda, Yoshihiro, Plitman, Eric, Honda, Shiori, Matsushita, Karin, Chavez, Sofia, Sawada, Kyosuke, Wada, Masataka, Matsui, Mie, Fujii, Shinya, Miyazaki, Takahiro, Chakravarty, M. Mallar, Uchida, Hiroyuki, Remington, Gary, Graff-Guerrero, Ariel, Mimura, Masaru, Nakajima, Shinichiro
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021829/
https://ncbi.nlm.nih.gov/pubmed/31842203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0589-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires